These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34456873)

  • 1. Purinergic Signaling in Liver Pathophysiology.
    Jain S; Jacobson KA
    Front Endocrinol (Lausanne); 2021; 12():718429. PubMed ID: 34456873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.
    Lu D; Insel PA
    Am J Physiol Cell Physiol; 2014 May; 306(9):C779-88. PubMed ID: 24352335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.
    Marques-da-Silva C; Burnstock G; Ojcius DM; Coutinho-Silva R
    Immunobiology; 2011; 216(1-2):1-11. PubMed ID: 20471713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridine adenosine tetraphosphate induces contraction of airway smooth muscle.
    Gui Y; Wang Z; Sun X; Walsh MP; Li JJ; Gao J; Zheng XL
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L789-94. PubMed ID: 21840961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2Y/P2X divide: How it began.
    Kennedy C
    Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological role of extracellular purinergic mediators in the control of intestinal inflammation.
    Kurashima Y; Kiyono H; Kunisawa J
    Mediators Inflamm; 2015; 2015():427125. PubMed ID: 25944982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X and P2Y receptors—role in the pathophysiology of the nervous system.
    Puchałowicz K; Tarnowski M; Baranowska-Bosiacka I; Chlubek D; Dziedziejko V
    Int J Mol Sci; 2014 Dec; 15(12):23672-704. PubMed ID: 25530618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended tool compounds and drugs for blocking P2X and P2Y receptors.
    Müller CE; Namasivayam V
    Purinergic Signal; 2021 Dec; 17(4):633-648. PubMed ID: 34476721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signaling in retinal degeneration and regeneration.
    Reichenbach A; Bringmann A
    Neuropharmacology; 2016 May; 104():194-211. PubMed ID: 25998275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological roles of purinergic signaling in the liver.
    Vaughn BP; Robson SC; Burnstock G
    J Hepatol; 2012 Oct; 57(4):916-20. PubMed ID: 22709619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic P2X, P2Y and adenosine receptors differentially modulate hippocampal gamma oscillations.
    Schulz SB; Klaft ZJ; Rösler AR; Heinemann U; Gerevich Z
    Neuropharmacology; 2012 Feb; 62(2):914-24. PubMed ID: 22001427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signaling in Alzheimer's disease.
    Erb L; Woods LT; Khalafalla MG; Weisman GA
    Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic signaling in the retina: From development to disease.
    Ventura ALM; Dos Santos-Rodrigues A; Mitchell CH; Faillace MP
    Brain Res Bull; 2019 Sep; 151():92-108. PubMed ID: 30458250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Essential and Synergistic Role of Purinergic Signaling in Guided Migration of Corneal Epithelial Cells in Physiological Electric Fields.
    Nakajima KI; Tatsumi M; Zhao M
    Cell Physiol Biochem; 2019; 52(2):198-211. PubMed ID: 30816668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
    Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
    Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic receptors in embryonic and adult neurogenesis.
    Oliveira Á; Illes P; Ulrich H
    Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic signaling in liver disease.
    Vaughn BP; Robson SC; Longhi MS
    Dig Dis; 2014; 32(5):516-24. PubMed ID: 25034284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mediators of purinergic signaling in human liver cell lines.
    Goree JR; Lavoie EG; Fausther M; Dranoff JA
    Purinergic Signal; 2014 Dec; 10(4):631-8. PubMed ID: 25194703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic signaling and the functioning of the nervous system cells.
    Puchałowicz K; Baranowska-Bosiacka I; Dziedziejko V; Chlubek D
    Cell Mol Biol Lett; 2015 Dec; 20(5):867-918. PubMed ID: 26618572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.